Media Newsroom of

Impopharma

255 Spinnaker Way (Unit 6)
Concord, Ontario (ON) L4K 4J1
Impopharma Launches New Corporate Logo and Website

Impopharma Launches New Corporate Logo and Website

Impopharma, Inc. today introduced a new corporate logo and unveiled an enhanced corporate website (www.impopharma.com) as part of a strategic re-branding to reflect the company's growth and progressive brand vision. This supports the growing need within the specialty pharmaceutical sector…

Impopharma Inc. Strengthens Management Team and Board of Directors

Impopharma Inc. today announced the following organizational changes: Named David Mayers as the Chief Operating Officer of the Company and appointed him to the Board of Directors, replacing Hanna Piskorz (co-founder), who has retired and will be stepping down from…

Impopharma Inc. and Breckenridge Pharmaceutical Inc. Enter Into an Asset-Purchase Agreement to Commercialize the Generic Version of a Leading Corticosteroid Product Upon FDA Approval

Impopharma Inc. (”Impopharma”) today announced that it has entered into an asset purchase, license, and commercialization agreement with Breckenridge Pharmaceutical, Inc. (“Breckenridge”). Under terms of the agreement, Breckenridge has acquired the ANDA, and upon FDA approval, will market and distribute the product in…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login